These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 29308305)
1. Early detection of lung cancer by using an autoantibody panel in Chinese population. Ren S; Zhang S; Jiang T; He Y; Ma Z; Cai H; Xu X; Li Y; Cai W; Zhou J; Liu X; Hu X; Zhang J; Yu H; Zhou C; Hirsch FR Oncoimmunology; 2018; 7(2):e1384108. PubMed ID: 29308305 [TBL] [Abstract][Full Text] [Related]
2. [Clinical value of tumor-associated autoantibodies in diagnosis of early non-small cell lung cancer]. Ren Z; Ding HM; Qian X; Pan SY Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Dec; 55(12):1426-1434. PubMed ID: 34963239 [No Abstract] [Full Text] [Related]
3. Diagnostic value of tumor-associated autoantibodies panel in combination with traditional tumor markers for lung cancer. Xu Y; Zhang W; Xia T; Liu Y; Bi Z; Guo L; Xie W; Xiang Y; Xu Z; Yu Z; Li Y; Bai L Front Oncol; 2023; 13():1022331. PubMed ID: 36874112 [TBL] [Abstract][Full Text] [Related]
4. Significance of tumor-associated autoantibodies in the early diagnosis of lung cancer. Du Q; Yu R; Wang H; Yan D; Yuan Q; Ma Y; Slamon D; Hou D; Wang H; Wang Q Clin Respir J; 2018 Jun; 12(6):2020-2028. PubMed ID: 29356386 [TBL] [Abstract][Full Text] [Related]
5. Development of Diagnosis Model for Early Lung Nodules Based on a Seven Autoantibodies Panel and Imaging Features. Xu L; Chang N; Yang T; Lang Y; Zhang Y; Che Y; Xi H; Zhang W; Song Q; Zhou Y; Yang X; Yang J; Qu S; Zhang J Front Oncol; 2022; 12():883543. PubMed ID: 35530343 [TBL] [Abstract][Full Text] [Related]
6. [Early diagnosis of subtype in early clinical stage lung adenocarcinoma by using an autoantibody panel and computed tomography]. Meng QC; Gao PR; Ren PF; Song YP; Li HL Zhonghua Yi Xue Za Zhi; 2019 Jan; 99(3):204-208. PubMed ID: 30669764 [No Abstract] [Full Text] [Related]
7. [Evaluation of the application value of seven tumor-associated autoantibodies in non-small cell lung cancer based on machine learning algorithms]. Hao Y; Wu LN; Lyu YT; Liu YZ; Qin XS; Zheng R Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Nov; 57(11):1827-1838. PubMed ID: 38008573 [No Abstract] [Full Text] [Related]
8. Improvement in the performance of an autoantibody panel in combination with heat shock protein 90a for the detection of early‑stage lung cancer. Chen Q; Zhu S; Jiao N; Zhang Z; Gao G; Zheng W; Feng G; Han W Exp Ther Med; 2023 Feb; 25(2):82. PubMed ID: 36741915 [TBL] [Abstract][Full Text] [Related]
9. Comparative Study of Autoantibody Responses between Lung Adenocarcinoma and Benign Pulmonary Nodules. Wang J; Shivakumar S; Barker K; Tang Y; Wallstrom G; Park JG; Tsay JC; Pass HI; Rom WN; LaBaer J; Qiu J J Thorac Oncol; 2016 Mar; 11(3):334-45. PubMed ID: 26896032 [TBL] [Abstract][Full Text] [Related]
10. Clinical value of tumor-associated antigens and autoantibody panel combination detection in the early diagnostic of lung cancer. Ouyang R; Wu S; Zhang B; Wang T; Yin B; Huang J; Wei W; Huang M; Zhang M; Wang Y; Wang F; Hou H Cancer Biomark; 2021; 32(3):401-409. PubMed ID: 34151844 [TBL] [Abstract][Full Text] [Related]
11. The Value of a Seven-Autoantibody Panel Combined with the Mayo Model in the Differential Diagnosis of Pulmonary Nodules. Ling Z; Chen J; Wen Z; Wei X; Su R; Tang Z; Hu Z Dis Markers; 2021; 2021():6677823. PubMed ID: 33688380 [TBL] [Abstract][Full Text] [Related]
12. The clinical value of combined detection of seven lung cancer-related autoantibodies in assisting the diagnosis of non-small-cell lung cancer. Chen G; Guo P; Zhao H; Zhao D; Yang D Biomark Med; 2024; 18(20):917-925. PubMed ID: 39360656 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of multiple tumor-associated autoantibodies in lung cancer. Zhang R; Ma L; Li W; Zhou S; Xu S Onco Targets Ther; 2019; 12():457-469. PubMed ID: 30666125 [TBL] [Abstract][Full Text] [Related]
15. Case study of an autoantibody panel for early detection of lung cancer and ground-glass nodules. Huo Y; Guo Z; Gao X; Liu Z; Zhang R; Qin X J Cancer Res Clin Oncol; 2020 Dec; 146(12):3349-3357. PubMed ID: 32648227 [TBL] [Abstract][Full Text] [Related]
16. Stem signatures associated antibodies yield early diagnosis and precise prognosis predication of patients with non-small cell lung cancer. Chen SS; Li K; Wu J; Peng ZY; Wang ZD; Wang JC; Xu CW; Zhu CL; Li BC; Ren H; Tang SC; Sun X J Cancer Res Clin Oncol; 2021 Jan; 147(1):223-233. PubMed ID: 32691153 [TBL] [Abstract][Full Text] [Related]
17. Clinical application of serum seven tumour-associated autoantibodies in patients with pulmonary nodules. Hu K; Gao L; Zhang R; Lu M; Zhou D; Xie S; Fan X; Zhu M Heliyon; 2024 May; 10(9):e30576. PubMed ID: 38765082 [TBL] [Abstract][Full Text] [Related]
18. The role of autoantibody detection in the diagnosis and staging of lung cancer. Wang Y; Jiao Y; Ding CM; Sun WZ Ann Transl Med; 2021 Nov; 9(22):1673. PubMed ID: 34988182 [TBL] [Abstract][Full Text] [Related]
19. Seven tumor-associated autoantibodies as a serum biomarker for primary screening of early-stage non-small cell lung cancer. Chen P; Lu W; Chen T J Clin Lab Anal; 2021 Nov; 35(11):e24020. PubMed ID: 34555232 [TBL] [Abstract][Full Text] [Related]
20. Systematic review: Tumor-associated antigen autoantibodies and ovarian cancer early detection. Fortner RT; Damms-Machado A; Kaaks R Gynecol Oncol; 2017 Nov; 147(2):465-480. PubMed ID: 28800944 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]